Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages Juan Carlos del Río-Valencia, Rocío Asensi-Díez, Lorenzo Villalobos-Torres, Ana Clopés-Estela, M.ª Dolores Fraga-Fuentes

Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group Asunción Albert-Marí, M.a Ángeles Gil-Lemus, David Conde-Estévez, Begoña San José-Ruiz, Inmaculada Jiménez-Pulido, M.a Jesús Esteban-Mensua, Ana Cristina Cercós-Lletí, M.a Sacramento Díaz-Carrasco

Review of oritavancin for the treatment of acute bacterial skin and skin structure infections Ana Alejandra García-Robles, Eduardo López Briz, María Dolores Fraga Fuentes, Rocío Asensi Díez, Jesús Francisco Sierra Sánchez